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Targeted Intestinal
Tight Junction
Hyperpermeability Alters the
Microbiome, Behavior, and
Visceromotor Responses
Markedly increases in intestinal
permeability occur in inflammatory
bowel disease, graft-versus-host dis-
ease, celiac disease, and multiple organ
dysfunction. In these diseases, effec-
tors of increased permeability include
immune signaling,1 microbiome,2 and
corticosteroids3 that, in part, signal
through epithelial myosin light chain
kinase (MLCK). More modest perme-
ability increases occur in other disor-
ders, including irritable bowel
syndrome (IBS), autism spectrum dis-
order, depression, and stress-related
disorders. However, data directly link-
ing barrier loss to phenotypes of these
diseases are lacking.A
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Figure 1. Increased intestinal permeability modifi
tracking paths of representative WT and CAMLCK
traveled in the center (dashed lines), percent time i
entire field are shown. CAMLCKTg (blue circles, n ¼
tested. Values are mean ± SEM. *P < .05; **P < .0
distension-induced visceromotor responses in C
relative to WT (red squares, n ¼ 7) littermates. Ge
MLCK inhibition, water avoidance stress, or nalox
treatment (vehicle control CAMLCKTg and WT mice
symbols in the last three graphs). Values are meanTo define the impact of modestly
increased intestinal permeability, we
studied transgenic mice with intestinal
epithelial-specific constitutively-active
myosin light chain kinase (CAMLCK)
expression. This MLCK-dependent
tight junction regulation increased in-
testinal permeability (Supplementary
Figure S1A and B).1 Nevertheless,
postnatal growth (Supplementary
Figure S1C), reproduction, intestinal
transit (Supplementary Figure S1D),
intestinal histology, epithelial prolifer-
ation (a sensitive indicator of epithelial
damage), and epithelial turnover are
unaffected in CAMLCK transgenic
(CAMLCKTg) mice.1 In contrast,
mucosal tumor necrosis factor-a,
interferon-g, interleukin (IL)-10, and
IL-13 transcripts as well as numbers of
lamina propria neutrophils, CD4þ T
cells, and IgAþ plasma cells are
modestly increased by CAMLCK
expression.1,2 Subclinical inflammation
is, therefore, present and, by0
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es behavior and visceral sensitivity. (A) Video-
Tg mice in the open field test. Percent distance
n the center, and overall distance traveled in the
8) and WT (red squares, n ¼ 9) littermates were
1, Mann-Whitney U test. (B) Stepwise colorectal
AMLCKTg (blue circles, n ¼ 7) were reduced
notype-specific differences were eliminated by
one treatment. n ¼ 5–9 per condition; for each
from the same experiment are shown with pale
± SEM. **, P < .01, 2-way analysis of variance.microbiome-dependent, IL-
17–mediated processes, affords partial
protection from acute pathogen inva-
sion.2 Immune activation is neverthe-
less unlikely to amplify CAMLCK-
driven permeability increases, as bar-
rier function and ZO-1 anchoring are
both acutely normalized by enzymatic
MLCK inhibition.1,4
We initially analyzed the gut
microbiome of 31 wild-type (WT) and
CAMLCKTg pups born to 8 WT dams.
The microbiomes segregated by pup
genotype but not dam (Supplementary
Figure S1E) and included increased
Clostridium and decreased Bacter-
oidetes, Enterococcus spp, and Pre-
votella in CAMLCKTg mice
(Supplementary Figure S1F). Increased
intestinal permeability can therefore
cause dysbiosis-like microbiome shifts.
Interestingly, maternal separation,
which increases intestinal perme-
ability, causes similar alterations and
can be partially corrected by
MLCK inhibitor–induced barrier
restoration.5
Microbiome alterations overlapping
with the above have been reported in
IBS and autism spectrum disorder. We
therefore asked if CAMLCKTg mice dis-
played anxiety-like behavior, as occurs
in those disorders, using the open field
test (Figure 1A). Both the percentage of
distance traveled in the center and the
fraction of time spent in the center of
the open field were reduced in
CAMLCKTg mice (Figure 1A); this did
not reflect reduced locomotor activity,
as total distance traveled in the entire
area was similar in CAMLCKTg and WT
mice (Figure 1A). These data are
consistent with increased anxiety-like
behavior in CAMLCKTg mice. Although
the results cannot differentiate be-
tween direct effects of increased
permeability and those requiring in-
termediate mediators, these data
demonstrate that intestinal perme-
ability increases can trigger behavioral
changes.
Stress and increased permeability
have been associated with enhanced
visceral sensitivity in humans and ro-
dents. Surprisingly, CAMLCKTg mice
displayed striking visceral analgesia to
colorectal distension relative to WT
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restored by enzymatic MLCK inhibi-
tion, water avoidance stress, or
naloxone-mediated opioid receptor
antagonism (Figure 1B). Although this
effect of increased permeability on
visceral sensitivity was unexpected, it
is remarkably similar to the naloxone-
reversible visceral analgesia reported
in chronically stressed female rats6
and naloxone-sensitive inhibition of
nociceptive neurons by supernatants
of colitic human and murine tissues.7
Studies of female IBS patients have
linked increased permeability to altered
functional and structural brain con-
nectivity.8 Thus, although responses to
colorectal distension can be mediated
by spinal reflexes as well as sensory,
limbic, and paralimbic regions of the
brain,9 we asked if neuronal activation
was modified by CAMLCK-induced
permeability increases. C-Fos immuno-
labeling, an indicator of neuronal ac-
tivity, was significantly greater in the
paraventricular nucleus of the thal-
amus, the paraventricular nucleus of
the hypothalamus, and the hippocam-
pus but not the medial prefrontal cor-
tex, nucleus accumbens, or amygdala of
CAMLCKTg, relative to WT, micec-
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Figure 2. Increased intestinal permeability
ing in selected brain regions. CAMLCKT
squares, n ¼ 5–6) littermates. Represen
brains from CAMLCKTg and WT mice. Scal
*P < .05, t test.(Figure 2, Supplementary Figure S2).
Increased intestinal permeability may
therefore increase basal neuronal ac-
tivity in areas of the brain that regulate
responses to visceral pain or stress9 but
not those associated with conscious
visceral sensation.
These results demonstrate that
increased intestinal permeability can
impact (1) gut microbiome composi-
tion, (2) behavior, (3) visceral pain
responses, and (4) neuronal activation
within the brain. Critically, these
changes are all results, rather than
causes, of intestinal barrier loss, as the
latter was induced by targeted
CAMLCK expression.
The sites of neuronal activation in
CAMLCKTg mice support the hypothesis
that increased intestinal permeability
can activate the hypothalamic-pituitary-
adrenal axis.10 Conversely,
hypothalamic-pituitary-adrenal axis
activation by exogenous stress can
induce intestinal permeability in-
creases.3 Thus, as has been proposed in
inflammatory bowel disease and graft-
versus-host disease, a self-amplifying
cycle may ultimately direct the diverse
phenotypes induced by MLCK-
dependent, intestinal permeabilitylar nucleus of the thalamus
 nucleus of the hypothalamus
hippocampus
CAMLCKTg
induces increased c-Fos immunolabel-
g (blue circles, n ¼ 5–6) and WT (red
tative images of c-Fos–immunolabeled
e bars ¼ 200 mm. Values are mean ± SD.increases. Further study is needed to
define the complex relationships be-
tween intestinal permeability, stress,
behavioral alterations, visceromotor re-
sponses, microbiome composition, and
other abnormalities.
These data are the first to assess
behavior in a model in which a tar-
geted increase in intestinal tight junc-
tion permeability is the only direct
perturbation. The results demonstrate,
unequivocally, that modest tight junc-
tion permeability increases induced via
a physiologically and pathophysiologi-
cally relevant mechanism are sufficient
to trigger local and systemic microbial,
behavioral, and neurosensory changes.
This provides a new perspective with
which to understand previously hy-
pothesized cause-effect relationships
that have been proposed on the basis
of correlative data.
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Supplementary Methods
Animals
CAMLCKTg mice1–4 (Tg(Vil-FLAG-
CAMLCK)#Jrt) were maintained as male
heterozygotes on C57BL/6J background.
These were mated with wild-type (WT)
C57BL/6J female mice to produce WT
and CAMLCKTg littermates. At weaning,
female mice were separated and housed
at constant temperature (22 ± 1C)
with a 12-hour light/dark cycle. Food
(Teklad 2018; Envigo, Indianapolis, IN)
and water were available ad libitum. All
experiments were performed at 8
weeks of age. Procedures were
approved by the Ethical Committee
CEEA-86, under the number
APAFiS#4145.
Gut Microbiota Composition
Analysis
Gut microbiota were analyzed in
two cohorts (15 WT and 16
CAMLCKTg) from 8 different WT dams.
At sacrifice, colonic contents were
stored at –80C. DNA was extracted
using the ZR fecal DNA MiniPrep kit
(Zymo Research, Irvine, CA) and
adjusted to 1 ng/mL. Changes in rela-
tive abundance of 24 microbial 16S
rRNA gene targets were obtained by
quantitative reverse-transcription po-
lymerase chain reaction (PCR) using
an adapted Gut Low-Density Array
platform.5–7 A universal bacterial
primer set was included as the refer-
ence gene. quantitative reverse-
transcription PCR was performed in
duplicate on a ViiA7 (Applied Bio-
systems, Foster City, CA).
Fluorescence data were imported
into LinRegPCR to perform baseline
corrections, calculate mean PCR effi-
ciency per amplicon group. and calcu-
late initial quantities. Among the 24
targeted amplicon groups, 6 were not
detected in any fecal samples and were
removed from the analysis (Bacteroides
vulgatus, Alistipes spp, Parabacteroidetes
distasonis, Roseburia spp, Escherichia
coli, and Akkermansia muciniphila).
Normalized N0-values were log10-trans-
formed and processed by mixOmics
(v6.1.1; https://www.bioconductor.org/
packages/release/bioc/html/mixOmics.
html) with RStudio (v1.0.44; RStudio,
Boston, MA) to build a partial least-
squares discriminant analysis. This
multivariate supervised approach pro-
jects samples (X) onto a low-
dimensional space of latent variables
to maximize separation between groups
according (Y ¼ genotype). Leave-one-
out cross-validation was used to select
the optimal number of latent variables
for partial least-squares discriminant
analysis models.
Open Field Test
Mice explored a 50  50 cm arena
(illumination 300 lx) for 10 minutes.
Exploration was automatically
assessed using a video tracking system
(Bioseb, Vitrolles, France). The per-
centage of distance traveled and time
spent and in the center area (20  20
cm) and total distance traveled in the
entire arena were assessed.
Colorectal Distension
Two 0.08-mm diameter electrodes
were implanted in the abdominal
external oblique muscle and a third in
the abdominal skin. On postoperative
days 3–6, colorectal distension (CRD)
was performed using a balloon catheter
(Fogarty 4F catheter [Edwards Life-
sciences, Irvine, CA], 1.1 cm length, tip
3.5 cm from the anus)8 in 10-second
periods with increasing volumes from
0.02 mL to 0.10 mL, with 5 minutes’ rest
between distensions. Abdominal elec-
tromyography activity was registered
after the amplification (10,000) and
analyzed (Powerlab Chart 5; ADInstru-
ments, Sydney, Australia). Basal electro-
myographic activitywas subtracted from
electromyographic activity registered
during distension. Some mice were
treated with ML-7 (2 mg/kg intraperi-
toneal) or naloxone sulfate (2 mg/kg
intraperitoneal) 1 hour before CRD. For
others, water avoidance stress was
inducedonafloatingplatform(33cm)
in themiddle of awater-filled tank (40
40 cm) for 1 hour daily over four days.
Recovery (30 minutes) preceded CRD.
Gastrointestinal Transit
Animals received 70 mL of 100-mg/
mL TRITC-70kDa dextran in tap water
by gavage and were sacrificed 1 hour
later.9 The stomach and small and large
intestine were cut in 11 equal parts.
Luminal contents of each segment
were centrifuged and fluorescence
determined. Transit was calculated as
the geometric center of the values for
each mouse.
Ussing Chamber Analysis
Jejunal sections were mounted in
Ussing chambers (Physiologic In-
struments, San Diego, CA) filled with
Krebs buffer and continuously
oxygenated (95% O2, 5% CO2). After 1
hour of equilibration, fluorescein (1
mg/mL) was added in the apical
chamber and fluorescence intensity of
the basolateral chamber was
measured after 1 hour.
In Vivo Permeability Analysis
Mice were fasted for 4 hours before
gavagewith 150 mL of 100-mg/mL FITC-
4kDa dextran in tap water. Blood (200
mL) was collected after 4 hours and
plasma fluorescence determined.
C-Fos Analysis
Vibratome sections (40 mm) were
stained using polyclonal rabbit anti-c-
Fos (Santa Cruz Biotechnology, Dal-
las, TX) and secondary horseradish
peroxidase–conjugated goat anti-
rabbit antisera (Jackson ImmunoR-
esearch, West Grove, PA). NDPI images
(20) were obtained (Nanozoomer;
Hamamatsu Photonics, Hamamatsu,
Japan) and converted into TIFF format
using ImageJ (NDPI tools plugin; Na-
tional Institutes of Health, Bethesda,
MD; https://imagej.nih.gov/ij, version
1.52a). Regions of interest were
manually circumscribed using
region-of-interest tools and
c-Fos–immunoreactive cells quantified
automatically using the particle anal-
ysis function (size: 5–20 mm2; circu-
larity: 0.5–1). For each animal, 3–6
sections of each brain area were
assessed by a blinded observer.
Statistical Analysis
Statistical significance was deter-
mined by 2-tailed t test, 2-tailed Mann-
Whitney U test, or 2-way analysis of
variance and set at P < .05. For micro-
bial analyses, univariate analysis was
realized in parallel to compare each
amplicon separately using unpaired t
test followed by the Benjamini-
Hochberg adjustment of P values for
multiple comparisons.
2020 African American IBD Gene Expression 208.e1
Supplementary References
1. Su L, et al. Gastroenterology 2009;136:551–563.
2. Weber CR, et al. J Biol Chem 2010;285:12037–12346.
3. Edelblum KL, et al. Cell Mol Gastroenterol Hepatol 2017;4:285–297.
4. Yu D, et al. Proc Natl Acad Sci U S A 2010;107:8237–8241.
5. Bergstrom A, et al. FEMS Microbiol Lett 2012;337:38–47.
6. Bergstrom A, et al. Appl Environ Microbiol 2014;80:2889–2900.
7. Riba A, et al. Gastroenterology 2017;153:1594–1606.e2.
W
ei
gh
t  (
g)
D
Age (weeks)
In
es
tin
al
 t r
an
si
t 
(g
e o
m
et
ric
 c
e n
te
r )
WT
CAMLCKTg 6
7
8
9
0 4 8 12
0
5
10
15
20
In
 v
iv
o 
pe
rm
ab
ili
ty
 (
no
rm
al
iz
ed
)
A B*
0
1
2
0.0
0.5
1.0
1.5
2.0
In
 v
itr
o 
pe
rm
ab
ili
ty
 (
no
rm
al
iz
ed
)
C
0-2 2-4
0
-2
2
-1
1
0.0-0.4 0.4
Prevotella
B. fragilis
C. butyricum
B. thetaiotaomicron
Bacteroides
Bifidobacterium
E. hallii
Bacteroides/Prevotella
Enterococcus
Bacteroidetes
Firmicutes
Desulfovibrio
C. Cluster IV
C. Cluster XIVa
R. gnavus
M. smithii
Enterobacteriaceae
-6
WT
CAMLCKTg
*
WT
CAMLCKTg
WT
CAMLCKTg
WT
CAMLCKTg
WT
CAMLCKTg
E F
PLS-DA (axis 1) 
P
LS
-D
A
 (a
xi
s 
2)
 
Supplementary Figure 1. (A)
Transjejunal fluorescein flux was
increased in CAMLCKTg (blue
circles) relative to wild-type (WT)
(red squares) littermates. Values
are mean ± SD. *P < .05. Mann-
Whitney U test. (B) In vivo anal-
ysis using FITC-4kDa dextran
demonstrated increased perme-
ability of CAMLCKTg (blue cir-
cles, n ¼ 19) relative to WT (red
squares, n ¼ 20) littermates.
Values are mean ± SD. *P < .05,
t test. (C) Weight gain was
similar in WT (red squares, n ¼
6) and CAMLCKTg (blue circles,
n ¼ 6) littermates. Values are
mean ± SD. (D) Intestinal transit
was similar in WT (red squares,
n ¼ 10) and CAMLCKTg (blue
circles, n ¼ 9) littermates. Values
are mean ± SD. (E) Partial least-
squares discriminant analysis
(PLS-DA) score plot based on
the relative abundances of 18
microbial taxa in gut contents of
CAMLCKTg (circles, n ¼ 16) and
WT (squares, n ¼ 15) born to 8
different dams (each
color represents 1 dam). (F) Relative abundances of microbial communities in CAMLCKTg (blue) and WT (red) mice. Diagrams indicate regions
analyzed.
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Figure 2. CAMLCKTg (blue circles,
n ¼ 5–6) and wild-type (WT) (red
squares, n ¼ 5–6) littermates.
Representative images of c-
Fos–immunolabeled brains from
CAMLCKTg and WT mice. Scale
bars ¼ 200 mm. Values are mean
± SD. *P < .05, t test.
2020 African American IBD Gene Expression 208.e3
